Jeffrey (Jeff) R. Gargano focuses his practice on litigation of disputes involving intellectual property in US federal courts and the International Trade Commission (ITC). He also counsels clients on overall intellectual property strategy and litigation avoidance. Jeff has litigated cases in state and federal courts and before administrative tribunals, including the US Patent and Trademark Office (USPTO) and the ITC, involving myriad intellectual property law issues, including domestic and foreign patents, trademarks, trade secrets, copyrights, false advertising and unfair competition.
Jeff has developed a particular concentration in strategy and patent litigation of disputes arising under the Hatch-Waxman Act, representing generic companies in district court litigation, inter partes review proceedings and appeals in over 25 cases, regarding drugs such as Clindesse®, Rapaflo®, Epiduo®, Pristiq®, Adapalene®, Taclonex®, Dovonex®, Solaraze®, Differin®, MetroGel®, Ortho TriCyclen Lo®, Evozac® and Nuvigil®. Jeff's experience allows him to help clients navigate the regulatory, patent and antitrust issues unique to Abbreviated New Drug Application (ANDA) litigation. Jeff is the founding editor of the McDermott publication ANDA UPDATE, a quarterly newsletter reporting on cases of interest in the pharmaceutical industry.
Jeff is also a registered patent attorney with a bachelor's degree in chemical engineering and has experience with many diverse technologies, including pharmaceutical compounds and formulations, methods for treating medical conditions, medical devices and surgical procedures, food sciences, 3G and 4G wireless telecommunications, equipment and methods for manufacturing semiconductive wafers and chips, circuit protection devices, integrated circuits, printed circuit boards, computer software and hardware, electro-luminescent materials for flat panel displays, water-soluble polymeric films, polymeric positive temperature coefficient (PTC) and cross-linking of polymeric materials, e-commerce, business methods and financial products and systems, fitness equipment and physical training methods, sporting equipment and head impact telemetry systems.
Prior to attending law school, Jeff worked as a test engineer for a large international semiconductor company. He earned his bachelor’s degree in chemical engineering.
Jeff also has deep knowledge of counseling Chinese companies looking to enter US markets on all aspects of US intellectual property and competition laws. He has lectured in China on all aspects of US intellectual property law.